Valeant Pharmaceuticals Intl Inc
General
Total Cases38
Active Cases2
Patents42
--
--
--
Ratings
Experience
Grade
Trend
DCT
L5
A
PTAB
L5
A
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 12/16/21 | ORAL ORDER: IT IS HEREBY ORDERED that the Court will hear oral argument on the pending motion on January 18, 2022 beginning at 2:00 p.m. in Courtroom 6B. Each side will be allocated up to twenty (20) minutes to present its argument. ORDERED by Judge Leonard P. Stark on 12/16/21. (ntl) | |
| 05/10/21 | DECLARATION re [183] Reply Brief in Support of Defendants' Motion for Attorneys' Fees by Actavis Laboratories FL Inc. , Actavis Pharma Inc. , Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc. . (Attachments: # [1] Exhibit 1)(Phillips, John) | |
| 05/10/21 | REPLY BRIEF re [171] MOTION for Attorney Fees filed by Actavis Laboratories FL Inc. , Actavis Pharma Inc. , Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc. . (Phillips, John) | |
| 05/03/21 | SO ORDERED, re [182] STIPULATION TO EXTEND TIME for Defendants to file their reply brief in support of their Motion for Attorneys' Fees Pursuant to 35 U.S.C. § 285 (D.I. 171) to May 10, 2021 filed by Teva Pharmaceutical Industries Ltd., Actavis Laboratories FL Inc. , Actavis Pharma Inc. , Teva Pharmaceuticals USA Inc. Signed by Judge Leonard P. Stark on 5/3/21. (ntl) | |
| 04/29/21 | STIPULATION TO EXTEND TIME for Defendants to file their reply brief in support of their Motion for Attorneys' Fees Pursuant to 35 U.S.C. § 285 (D.I. 171) to May 10, 2021 - filed by Actavis Laboratories FL Inc. , Actavis Pharma Inc. , Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc. . (Phillips, John) | |
| 04/26/21 | DECLARATION re [180] Answering Brief in Opposition, -- Declaration of Christopher M. Bruno -- by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International. (Attachments: # [1] Exhibits 1-2)(Blumenfeld, Jack) | |
| 04/26/21 | ANSWERING BRIEF in Opposition re [171] MOTION for Attorney Fees and Response to Bill of Costs [168] filed by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International.Reply Brief due date per Local Rules is 5/3/2021. (Blumenfeld, Jack) | |
| 04/06/21 | SO ORDERED, re [179] STIPULATION TO EXTEND TIME for plaintiffs to respond to defendants' attorneys' fees motion and cost request (D.I. 168-173) to April 26, 2021 filed by Salix Pharmaceuticals Ltd., Cosmo Technologies Limited, Valeant Pharmaceuticals International. Signed by Judge Leonard P. Stark on 4/6/21. (ntl) | |
| 04/05/21 | STIPULATION TO EXTEND TIME for plaintiffs to respond to defendants' attorneys' fees motion and cost request (D.I. 168-173) to April 26, 2021 - filed by Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International. (Blumenfeld, Jack) | |
| 04/05/21 | REDACTED VERSION of [173] Declaration, by Actavis Laboratories FL Inc. , Actavis Pharma Inc. , Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc. . (Bilson, David) |